FeesSafety
Pluang+

Shoulder Innovations reports 38% revenue growth in Q3 2026, raises full-year guidance to $68-70M.

Company Fundamentals
05 Nov 2026, 23:11 WIB
PRNewsWire
View Source
Bullish
Shoulder Innovations reports 38% revenue growth in Q3 2026, raises full-year guidance to $68-70M.

Shoulder Innovations, a medical tech company focused on shoulder surgical care, reported a 38% increase in Q3 2026 revenue to $16.2 million, driven by higher implant sales and prices. The company raised its 2026 revenue guidance to $68-$70 million, reflecting 44%-48% growth over 2025. Despite an operating loss of $7.6 million, net loss narrowed compared to last year. The company also advanced its product pipeline with new implant launches and partnerships, aiming for continued growth into 2027.

Shoulder Innovations' third quarter 2026 financial results provide context for health sector performance. For readers following the health sector, here is Pluang's market snapshot as of Nov 06, 2026 04:11 WIB: out of 150 priced US health stocks, 16 rose and 134 fell. Notable movers include NUWE at USD 4.60 with a 12.71% decline, NUVB at USD 4.19 down 11.42%, and HIMS at USD 23.62 down 11.40%.

More News

Strawberry Fields REIT declares Q4 2026 cash dividend of $0.17 per share payable Dec 30.

Strawberry Fields REIT declares Q4 2026 cash dividend of $0.17 per share payable Dec 30.

Strawberry Fields REIT announced a cash dividend of $0.17 per common share for the fourth quarter of 2026. The dividend will be paid on December 30, 2026, to shareholders recorded by December 16, 2026. The company specializes in owning and leasing he...

Company Fundamentals
Neutral
17 minutes ago
Globe Life declares $0.33 quarterly dividend payable February 1, 2027.

Globe Life declares $0.33 quarterly dividend payable February 1, 2027.

Globe Life Inc. announced a quarterly dividend of $0.33 per share for shareholders of record as of January 8, 2027. This dividend will be paid on February 1, 2027. Globe Life is a holding company focused on life and supplemental health insurance for ...

Company Fundamentals
Neutral
5 hours ago
Volatus Aerospace to report Q3 2026 financial results on Nov 10 with a live webinar.

Volatus Aerospace to report Q3 2026 financial results on Nov 10 with a live webinar.

Volatus Aerospace Inc., a global aerospace and defence company, will announce its financial results for the third quarter and nine months ended September 30, 2026, on November 10, 2026, after market close. The company will host a webinar featuring it...

Company Fundamentals
Neutral
5 hours ago
Cytek Aurora Evo wins 2026 BioTech Breakthrough Award for drug discovery innovation.

Cytek Aurora Evo wins 2026 BioTech Breakthrough Award for drug discovery innovation.

Cytek Biosciences' Cytek Aurora Evo system was named Drug Discovery Innovation of the Year in the 2026 BioTech Breakthrough Awards for its advanced spectral flow cytometry technology. The system offers higher throughput, automation, and reproducible ...

Market News
Bullish
5 hours ago
Quantum BioPharma corrects share consolidation details and caps voting power at 70% ahead of Nov 10 shareholder meeting

Quantum BioPharma corrects share consolidation details and caps voting power at 70% ahead of Nov 10 shareholder meeting

Quantum BioPharma filed a supplement to its management circular correcting the treatment of fractional shares in its proposed share consolidation. Fractions of shares will be rounded up or down based on size. The company also clarified that voting po...

Company Fundamentals
Neutral
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App